David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
1026
DELISTED
NanoString Technologies, Inc.
NSTG
| $12.7M | 0.01% |
458,075
-35,462
| -7% | -$861K |
|
1027
PUT
Spotify
SPOT
$114B
| $12.7M | 0.01% |
85,200
+32,000
| +60% | +$4.39M |
|
1028
Bunge Global
BG
$21.5B
| $12.7M | 0.01% |
220,734
+191,390
| +652% | +$10.6M |
|
|
BPMC
1029
DELISTED
Blueprint Medicines
BPMC
| $12.7M | 0.01% |
158,270
+47,339
| +43% | +$3.54M |
|
1030
Telephone and Data Systems
TDS
$3.89B
| $12.6M | 0.01% |
495,278
-93,783
| -16% | -$2.3M |
|
1031
SPS Commerce
SPSC
$2.9B
| $12.6M | 0.01% |
226,545
-31,935
| -12% | -$1.7M |
|
1032
PUT
Public Storage
PSA
$60.3B
| $12.5M | 0.01% |
58,800
+10,000
| +20% | +$2.22M |
|
|
TVTY
1033
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $12.5M | 0.01% |
615,280
-639,149
| -51% | -$12M |
|
1034
PUT
HSBC
HSBC
$358B
| $12.5M | 0.01% |
320,000
+219,100
| +217% | +$8.31M |
|
|
LTRPA
1035
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $12.5M | 0.01% |
1,697,061
-45,825
| -3% | -$369K |
|
1036
CACI
CACI
$13.5B
| $12.5M | 0.01% |
49,876
-4,375
| -8% | -$1.02M |
|
1037
PUT
Wynn Resorts
WYNN
$10.2B
| $12.5M | 0.01% |
89,700
-47,200
| -34% | -$5.74M |
|
1038
CALL
Carnival Corporation Ltd
CCL
$35.8B
| $12.4M | 0.01% |
244,600
+43,300
| +22% | +$1.93M |
|
1039
PUT
Alcoa
AA
$13.5B
| $12.4M | 0.01% |
577,000
+214,600
| +59% | +$4.44M |
|
1040
Belden
BDC
$4.57B
| $12.4M | 0.01% |
225,458
-111,043
| -33% | -$5.93M |
|
1041
CALL
Aon
AON
$75.3B
| $12.4M | 0.01% |
59,500
+32,700
| +122% | +$6.47M |
|
|
CXO
1042
PUT
DELISTED
CONCHO RESOURCES INC.
CXO
| $12.4M | 0.01% |
141,200
-40,400
| -22% | -$2.92M |
|
1043
Adtran
ADTN
$653M
| $12.3M | 0.01% |
1,248,599
+196,714
| +19% | +$1.87M |
|
1044
Radware
RDWR
$1.17B
| $12.3M | 0.01% |
478,199
+83,641
| +21% | +$1.98M |
|
1045
Black Hills Corp
BKH
$5.57B
| $12.3M | 0.01% |
156,929
-48,694
| -24% | -$3.75M |
|
1046
CALL
Teva Pharmaceuticals
TEVA
$44.4B
| $12.3M | 0.01% |
1,255,900
+396,200
| +46% | +$3.54M |
|
|
GTS
1047
DELISTED
Triple-S Management Corporation
GTS
| $12.3M | 0.01% |
664,356
+52,560
| +9% | +$896K |
|
1048
CALL
Estee Lauder
EL
$37.9B
| $12.3M | 0.01% |
59,400
-13,600
| -19% | -$2.64M |
|
1049
Masco
MAS
$14.4B
| $12.3M | 0.01% |
255,340
-290,338
| -53% | -$13.2M |
|
|
CHX
1050
DELISTED
ChampionX
CHX
| $12.2M | 0.01% |
362,218
+88,068
| +32% | +$2.4M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.